Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-12 · accession 0001968202-23-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-14 | 2023-12-12 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $856.71 | -7,657 | 48.3K | -14% | -$6.56M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-12 | F | D | 7,657 | $856.71 | 48,306 | D | — | — |